Why the study?
Does the degree of carotid plaque enhancement on contrast-enhanced ultrasound correlate with clinical symptoms of TIA or stroke?
Does the degree of carotid plaque enhancement on contrast-enhanced ultrasound correlate with clinical symptoms of TIA or stroke?
Contrast-enhanced carotid ultrasound reveals significantly greater plaque enhancement in symptomatic patients, suggesting its potential utility for plaque risk stratification.
Answers are grounded in this paper and cite their sources.
May inform carotid plaque risk stratification; hypothesis-generating and should not change practice without prospective validation.
PURPOSE: To determine the correlation between the degree of plaque enhancement with contrast agent microbubbles and clinical symptoms in patients with carotid atherosclerotic plaque. MATERIALS AND METHODS: The study was approved by the hospital ethical committee, and informed consent was obtained from all patients. One hundred four patients (83 men: mean age, 64 years +/- 9 [standard deviation]; 21 women: mean age, 61 years +/- 10) with carotid plaques were studied with standard and contrast material-enhanced ultrasonography (US). Contrast enhancement in the plaque was evaluated with visual interpretation and quantitative analysis. RESULTS: Among the 104 patients, 35 (34%) had transient ischemic attack and/or cerebrovascular ischemic stroke. Plaque enhancement was found in 28 (80%) of 35 symptomatic patients and in 21 (30%) of 69 asymptomatic patients (P < .001). Enhanced intensity in the plaque (13.9 dB +/- 6.4) and the ratio of enhanced intensity in the plaque to that in the lumen of the carotid artery (0.54 +/- 0.23) in symptomatic patients were significantly greater than those in asymptomatic patients (8.8 dB +/- 5.2 [P < .001] and 0.33 +/- 0.19 [P < .001], respectively). Sensitivity and specificity were 74% and 62%, respectively, for enhanced intensity in the plaque (cutoff value, 10.0 dB) and 74% and 75%, respectively, for ratio of enhanced intensity in the plaque to that in the lumen of the carotid artery (cutoff value, 0.46). CONCLUSION: Symptomatic patients had more intense contrast agent enhancement in the plaque than asymptomatic patients, suggesting that contrast-enhanced carotid US may be used for plaque risk stratification.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: